Literature DB >> 2929419

Compliance packaging: a patient education tool.

D L Smith.   

Abstract

As a direct response to the profound negative impact that the high rate of noncompliance is having on therapeutic efficacy and total health-care costs, some pharmaceutical manufacturers have taken steps to develop compliance packaging for some products prescribed for ambulatory patients. The purpose of compliance packaging is to serve as a patient-education tool for health professionals and to make it easier for patients to remember to take their medications correctly at home. The ideal compliance package will be developed according to patient-education guidelines. Compliance packaging holds promise as a significant patient-education tool when health professionals combine it with personalized patient counseling and well-written medication instructions. Well-controlled cost-effectiveness studies are needed to determine the impact of compliance packaging on reducing total health-care costs.

Entities:  

Mesh:

Year:  1989        PMID: 2929419     DOI: 10.1016/s0160-3450(15)31856-0

Source DB:  PubMed          Journal:  Am Pharm        ISSN: 0160-3450


  7 in total

1.  Noncompliance in the elderly. Is there a cure?

Authors:  R B Stewart
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

2.  Strategies to enhance patient adherence: making it simple.

Authors:  Ashish Atreja; Naresh Bellam; Susan R Levy
Journal:  MedGenMed       Date:  2005-03-16

3.  Mitigating the Burden of Type 2 Diabetes: Challenges and Opportunities.

Authors: 
Journal:  Am Health Drug Benefits       Date:  2015-04

4.  [The influence of drug packaging on the drug-taking compliance of older patients living on their own].

Authors:  Rudolf Schoberberger; Katharina Klik; Tassilo Korab; Michael Kunze
Journal:  Wien Med Wochenschr       Date:  2007

Review 5.  Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People.

Authors:  Carlotta Lunghi; Caterina Trevisan; Michele Fusaroli; Valentina Giunchi; Emanuel Raschi; Elisa Sangiorgi; Marco Domenicali; Stefano Volpato; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-08

6.  Noncompliance in neurologic patients.

Authors:  David B Weiss; Thomas P Beresford; Robert M House
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972

7.  The challenge of patient adherence.

Authors:  Leslie R Martin; Summer L Williams; Kelly B Haskard; M Robin Dimatteo
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.